Adam Muzikant - Jun 21, 2021 Form 4 Insider Report for Flexion Therapeutics Inc (FLXN)

Role
Chief Business Officer
Signature
/s/ Mark S. Levine, Attorney-in-Fact
Stock symbol
FLXN
Transactions as of
Jun 21, 2021
Transactions value $
$16,190
Form type
4
Date filed
6/28/2021, 06:13 PM
Next filing
Jul 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLXN Common Stock Award $16.2K +2.08K +2.01% $7.78 106K Jun 21, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 2,081 shares by the Reporting Person on June 21, 2021, pursuant to the Issuer's Employee Stock Purchase Plan.